Joel R. Jung - 02 May 2022 Form 4 Insider Report for MINERVA SURGICAL INC

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Aug 2022, 21:23:42 UTC
Prior SEC filing
17 Dec 2021
Next SEC filing
05 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Lenka Schvaigerova, Attorney-in-fact for Joel R Jung

Key filing fact

Joel R. Jung filed Form 4 for MINERVA SURGICAL INC on 09 Aug 2022.

Key facts

  • This page summarizes Joel R. Jung's Form 4 filing for MINERVA SURGICAL INC.
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Aug 2022, 21:23.

Change

  • Previous filing in this sequence was filed on 17 Dec 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTRS transaction

Common Stock

Award

Transaction value
$0
Shares
+60,198
Change %
+37%
Price
$0.000000
Shares after
220,730
Date
02 May 2022
Ownership
Direct
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

60,198 of the securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 25% of the RSUs will vests on May 16, 2023, and additional 25% of the RSUs will vest annually thereafter, subject to the Reporting Person continuing as a service provider through each such date.

Footnote F2

24,500 of these securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs vest on on December 15, 2022, subject to the Reporting Person continuing as a service provider on such date.

Footnote F3

136,032 shares were acquired pursuant to the exercise of an early-exercise option and remain subject to a right of repurchase by the Company, which shall lapse with respect to one-fourth of the shares on July 22, 2021 and with respect to one thirty-sixth of the remaining shares each month thereafter.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .